Mandate

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

July 03, 2026 M&A FDI Banking and Finance

Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.

EMPWR Nutrition Group is a Belgium-headquartered contract development and manufacturing organisation of nutritional bars, operating four manufacturing facilities in Croatia, the Netherlands, the United States and Canada, with over 1,500 employees and more than 100 customers globally. EMPWR Nutriton Group has been an important manufacturing partner for Vitamin Well, producing the full range of Barebells bars for markets globally. Established in 2006 and headquartered in Stockholm, Vitamin Well is a high-growth functional food and beverage business, offering premium products for consumers with approximately 750 employees and products sold in over 50 markets worldwide. As part of the transaction, Waterland Private Equity Investments will reinvest and become a minority shareholder in Vitamin Well.

The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of Daniel Rosvall, Kim Bergman Aldevinge and Michella Said (M&A), Sebastian Örndahl and Alva Chambert (Antitrust & FDI), Albert Wållgren, Karl-Gustaw Tobola and Nilufer Nouri (Banking and Finance) and Emy Rydén (Transaction Support Coordinator). With respect to local law advice, Covington advised on US law matters, NautaDutilh advised on Dutch and Belgian law matters, Gowling advised on Canadian law matters and Divjak, Topic, Bahtijarevic & Krka advised on Croatian law matters.

Related

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026

Vinge advises Ambea on the public offer for Humana

Ambea AB (publ) has made a public offer for all shares in Humana AB. The offer values all shares in Humana at approximately SEK 2,96 billion. The consideration consists of a mix of shares, cash and a CVR (contingent value right).
June 29, 2026